Yuanyan Wei

NHC Key Laboratory Of Glycoconjuates Research
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Deciphering the cell surface glyco-code: a promising perspective on unveiling the vulnerability of cancer stem cells.

Deciphering the cell surface glyco-code: a promising perspective on unveiling the vulnerability of cancer stem cells.

Journal: Cancer biology & medicine
Published: December 12, 2024

Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N.

Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N.

Journal: STAR protocols
Published: March 13, 2024

The Interaction between Collagen 1 and High Mannose Type CD133 Up-Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells.

The Interaction between Collagen 1 and High Mannose Type CD133 Up-Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 15, 2023

Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction.

Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction.

Journal: Cell reports
Published: August 26, 2022

Siglec15 promotes the migration of thyroid carcinoma cells by enhancing the EGFR protein stability.

Siglec15 promotes the migration of thyroid carcinoma cells by enhancing the EGFR protein stability.

Journal: Glycobiology
Published: May 20, 2022

The Interaction between DNMT1 and High-Mannose CD133 Maintains the Slow-Cycling State and Tumorigenic Potential of Glioma Stem Cell.

The Interaction between DNMT1 and High-Mannose CD133 Maintains the Slow-Cycling State and Tumorigenic Potential of Glioma Stem Cell.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 16, 2022

Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44.

Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44.

Journal: FEBS letters
Published: March 20, 2021

The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells.

The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells.

Journal: Cancer letters
Published: March 02, 2021

N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.

N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.

Journal: FEBS letters
Published: May 29, 2019

Complex N-glycan promotes CD133 mono-ubiquitination and secretion.

Complex N-glycan promotes CD133 mono-ubiquitination and secretion.

Journal: FEBS letters
Published: February 05, 2019

IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells.

IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells.

Journal: Journal of hepatology
Published: November 27, 2018

O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.

O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.

Journal: Journal of cellular and molecular medicine
Published: March 11, 2018
Showing 1-12 of 18

Last Updated: 09/26/2026